AmideBio

US-based biotechnology company (Louisville, CO) specializing in novel peptide drug candidates targeting metabolic disease. Leverages in-silico design and proprietary peptide synthesis. Offers custom peptide synthesis services and catalog peptides. Provides high purity, low-cost peptide solutions for pharmaceutical and biotech customers. True CDMO/drug discovery company.

Directory assessment: AmideBio is listed as a CDMO in the peptide supply chain, serving North America markets from USA (Colorado). As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is based on publicly available information and cross-referenced against industry databases. This supplier has a medium confidence score — verification signals are present, but the listing is newer or less documented; perform standard due diligence before engaging.